point-of-care diagnostics

Aviana Molecular Technologies, LLC (Aviana) is an Orlando, FL based point of care (POC) diagnostic company developing a miniaturized biosensor capable of attaching to a smartphone or smart device through Bluetooth or other wireless connections. Its diagnostic system is a simple-to-use, potentially highly sensitive platform that can detect a target infectious disease, biomarkers or proteins within 10-20 minutes in clinical (human and animal) and scientific research settings. The company was founded in 2008.

biosensor developmentmobile health data captureRF sensor technology

Barry Road Partners, LLC delivers actionable data to governments and health officials to manage and enhance community well-being. Through its Stercus Bioanalytics and Express Health offerings, it provides wastewater epidemiology analytics to combat the opioid crisis and point of care and at-home STI diagnostic collection kits delivered to hospitals and health clinics with next day results.

at-home diagnostic collection kitsdata collection and analysisdiagnostic testingwastewater epidemiology

Bench in a Box Technologies is developing a transformative diagnostic platform designed to overcome the limitations of PCR/qPCR in field and low-resource environments. Its patent-pending Template-Assisted Refolding Assay (TARA) platform enables highly specific, electricity-free molecular detection at room temperature, delivering results in ≤5 minutes without refrigeration or lab infrastructure. The company is based in Bay City, MI.

diagnostic assay developmentenzyme-free molecular detectionmolecular diagnostics

Burst Diagnostics is a growing diagnostics company on a mission to empower users with simple, accurate diagnostics when and where they're needed. Its CaDI platform delivers rapid, quantitative, lab-quality immunoassay testing in a compact cartridge, from point of need to at-home use. The company also offers custom assay development for partners across industries.

custom assay developmentmicrofluidicsquantitative immunoassay testing

Captihue is developing affordable at-home PCR-style molecular tests for infectious diseases, with results available in under 30 minutes. The company is also developing a molecular point-of-care solution with reusable instruments intended to provide PCR-level accuracy at low cost for clinics and resource-limited settings. Captihue is located in San Diego, California.

molecular diagnostic testingPCR-style testing

ControlPoint is a veterinary diagnostics company focused on developing rapid, point-of-care diagnostic tests for respiratory infections in animals. It is developing a single-use, disposable, hand-held test for use in veterinary clinics to aid in the detection of kennel cough, designed to detect multiple pathogens and deliver results within minutes, with results viewable via a QR code on the ControlPoint mobile app. The company also announced it will soon be selling antibodies against bacteria and viruses associated with upper respiratory infections in do

lateral flow testingmobile app results reportingrapid diagnostic test development

Darwin Biosciences develops a point-of-care diagnostic platform that uses a non-invasive saliva-based test and a unique biomarker panel to detect the immune signature indicative of acute-phase infections. The self-contained device works independent of laboratories and power sources, and is designed for earlier detection and smarter disease management, including early sepsis detection. The company was founded in March 2020 and pivoted into COVID-19 detection.

heater activationresults presentationRNA amplificationsaliva collectionsaliva processingswab insertion

DigitalXHealth, LLC brings healthtech to the edge, serving overlooked, operationally complex sectors like corrections, underserved communities, defense, and law enforcement. It delivers digital solutions, connected care tools, and services tailored to environments where traditional healthcare doesn't reach, from point-of-care diagnostics to AI-enabled software. Its mission starts with justice-involved communities to improve health and reduce recidivism.

AI-enabled softwaredigital therapeuticstelemedicinevirtual coaching

Early Charm is a vertically integrated company that takes science from research institution licenses to commercial production, with R&D and manufacturing under one roof in Baltimore, Maryland. It serves both defense and commercial markets, developing dual-use products across advanced materials, bioengineering and biodefense, and sensors and analytics. The company reports 90 products in its pipeline and 11 fully commercial products, and is an SBIR/STTR awardee that is DCAA-compliant and SAM + CAGE registered.

3D bioprinting3D printingbiomanufacturingcastingcoatingcomputational drug designcustom material formulationData Analyticselectrospinningoptical systemsprecision prototypingsonar-based monitoringspectroscopysurface engineering

Echolight Medical Corp provides an FDA-approved, portable and radiation-free diagnostic solution to assess bone density and fragility using R.E.M.S. (Radiofrequency Echographic Multi-Spectrometry) ultrasound technology for prevention, early diagnosis, and monitoring of bone health. Its devices deliver clinically validated results in minutes and are designed for physician offices, wellness centers, and mobile clinics.

body composition analysisfracture risk assessmentfragility scoringradiation-free scanningultrasound-based bone density assessment

ElectraDx develops affordable, portable point-of-care diagnostic testing technology. Its platform is designed to deliver lab-quality results in minutes from a small fluid sample, testing for multiple analytes, starting with NT-proBNP for early heart failure detection in GP surgeries, community clinics, pharmacies and homes.

early detection testingmulti-analyte testing

EoSight Diagnostics, Inc. was founded by scientists from Pharma, Academia, and Healthcare. The company focuses on transforming chronic rhinosinusitis care through point-of-care diagnostics, developing molecular biomarker-based diagnostic technologies.

molecular biomarker-based diagnostics

FlexBioTech Inc. provides advanced molecular diagnostic systems that are portable and affordable, enabling rapid and accurate detection of diseases such as high-risk human papilloma virus (HPV). Their cartridge-based, multi-purpose point-of-care systems deliver swift and precise results in the clinic, in the field or at home, supporting decentralized infectious disease management. The company aims to transform healthcare from reactive and hospital-centered to preventative, proactive and person-centered.

biomarker-based assay developmentmedical diagnostic electronic instrumentsmicrofluidics and electronics design

Hemex Health develops point-of-care blood diagnostics. Its Gazelle diagnostic platform detects and quantifies blood-based conditions including sickle cell disease, beta thalassemia, and iron-related and chronic conditions, delivering quantitative biomarker data. Founded in 2016 by Patti White and Peter Galen, Gazelle has been available in over 40 countries since its 2021 introduction and is sold through full-service medical distributors.

manufacturing via Indian partnersmicrochip electrophoresisproduct developmentR&D

InnoTech Precision Medicine develops a minimally equipped medical diagnostics platform and a liquid biopsy assay that combines genetic profiling, phenotyping, and explainable AI to flag early-stage head-and-neck cancer in less than 30 minutes in a clinician's office. The company's mission is to make early cancer detection easy and accessible through a fast, painless test, and it is looking for strategic partners and collaborators.

explainable AIgenetic profilingliquid biopsymultimodal detectionphenotyping

InnSight Technology is an innovative tear fluid analytic company dedicated to translational research initiatives that advance diagnostics and evaluation of eye and systemic disease. Its primary focus is providing an objective measurement of tear fluid biomarkers to standardize treatment solutions for dry eye and systemic disease, enabling detection of hard-to-diagnose diseases by collecting and analyzing tear fluid non-invasively.

clinical operationselectrochemical sensor technologyproduct developmentresearch and developmenttear fluid analysistranslational research